Testing and Toxicology of Designer Drugs

forensic toxicology

Article overview: This article explains Testing and Toxicology of Designer Drugs and the scientific, legal or practical evidence readers should understand.

Forensic Toxicology of Designer Drugs There are several goals of forensic toxicologists, including improving methods to identify and analyze samples from a person that may indicate a presence of drugs. This type of service can be used in a number of scenarios, from murder investigations, to employee drug testing, to health care. Another goal of forensic toxicologists, in a world where new and changing designer drugs are popping up on a frequent basis, is to develop and update methods for detecting these emerging drugs. What are Designer Drugs? “Designer synthetic drugs” is the term used to refer to drugs that are manufactured and created in a laboratory. Typically this is an illegal laboratory, which alters the properties of a drug to produce a new drug. Often this procedure involves an illegal drug that is combined with a prescription medication in order to create a new substance. These types of newly designed drugs often give users a different high than the original form of the drug. These types of drugs, while increasingly popular on the street, are also extremely dangerous. These illegally-made drugs, which can vary in their potency, are often contaminated with other types of drugs and harmful substances, and can produce dangerous side effects in those who take them. Some examples of designer drugs include Ecstasy (MDMA), GHB, LSD, methamphetamine, and bath salts. What is Forensic Toxicology? Forensic toxicology is a branch of forensic science that uses methods to aid investigations that involve drug use, poisoning, or questionable deaths. By using biological samples, forensic toxicologists use analytical and clinical chemistry, as well as pharmacology, to determine if there are any substances within the urine or blood sample. Forensic toxicologists, autopsy reports, coroners, and law enforcement officials are seeing more and more reports that indicate the presence of designer drugs within samples. The methods for forensic toxicologists must be constantly updated and progressive in order to detect these new synthetic drugs that are becoming more prominent in our society. How can Forensic Toxicology Detect New Synthetic Designer Drugs? It is the speed that new designer drugs are emerging that poses the biggest problem for forensic toxicologists. Positive drug detection comes from complex scientific processes of biological samples. In order to detect emerging designer drugs, forensic toxicologists are required to constantly modify and update their methods to be able to detect a broader span of modifications being made to traditional drugs. Detection of designer drugs will continue to be a challenge for scientists. As the varieties of these types of drugs are made illegally, in illegal facilities, the ingredients in each batch of drugs will vary. This makes detection of a specific type of designer drug, as well as emerging drugs, especially difficult. Forensic toxicologists, such as Okorie Okorocha, have done a great job of developing faster and more efficient analytical methods, as well as developing new analytical methods, to detect designer drugs in biological samples. In addition, forensic toxicologists are constantly trying to improve the interpretation of the toxicology data for aiding in investigations. The input of forensic toxicologists helps to improve the understanding of the relationships of designer drug concentration and the human body.
Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Hundreds of Plasma Specimens Still Came From Six THC Participants

The study’s 264 plasma specimens did not represent 264 independent cannabis users. Repeated sampling increased information about each participant’s profile while leaving the human sample small. The denominator depended on the question The intensive inpatient study enrolled six established cannabis users and repeatedly measured cannabinoids during and after oral dronabinol…

Spread the love

Read Article: Hundreds of Plasma Specimens Still Came From Six THC Participants

Metabolite Ratios Rose During Repeated Oral THC While Parent THC Did Not Accumulate Similarly

During repeated dosing, 11-hydroxy-THC and THC-COOH increased over time without the same accumulation pattern for parent THC. A stable parent profile did not mean all measured cannabinoid exposure remained stable. The analytes followed different courses The six-person plasma study compared repeated oral dosing with measurements associated with cannabis use before…

Spread the love

Read Article: Metabolite Ratios Rose During Repeated Oral THC While Parent THC Did Not Accumulate Similarly

Repeated Oral THC Increased Daily Dose by Changing Administration Frequency

The intensive oral-THC regimen repeatedly used 20 mg capsules while shortening the intervals between administrations. A higher daily total did not mean every individual capsule dose became larger. The schedule defined exposure Six daily cannabis users received dronabinol at increasing frequency, with intervals described as every four to eight hours…

Spread the love

Read Article: Repeated Oral THC Increased Daily Dose by Changing Administration Frequency

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us